top of page

Our news

Team-picture-_2-scaled-e1748412339285.jpg

kyron.bio Announces a €5.5M Seed Round

2025

unnamed.jpg

kyron.bio Relocates to Paris Biotech Santé at Hôpital Cochin

2025

Screenshot 2025-02-05 at 13.56.30.png

kyron.bio awarded 2025 EIC Transition​

2025

Screenshot 2024-11-04 at 16_edited_edited.jpg

kyron.bio attends Bio-Europe 2024

2024

Screenshot 2024-11-06 at 12.38.20.png

kyron.bio attends Bio-Europe 2024

2024

Screenshot 2024-11-26 at 12.00.11.png

kyron.bio selected as Deep Tech Pioneer

2024

kyron.bio in the news

Maddyness

Kyron.bio veut développer des médicaments pour lutter contre les cancers

BioPharm International

Kyron.bio Raises €5.5M to Advance Precision Glycan Engineering for Safer Antibody Therapeutics

Forbes

Meet The Biotech Innovator Flying The Flag For Europe’s Women Founders

European Medical Journal

Kyron.bio lands €5.5m to refine biologic drug design

French Web

Kyron.bio lève 5,5 millions d’euros pour industrialiser la glyco-ingénierie thérapeutique

Forbes

Classement : le top 10 des plus grandes levées de fonds de la French Tech en mai 2025

EU-Startups

Paris-based kyron.bio secures €5.5 million to tackle drug efficiency and safety

Silicon Canals

French female-led biotech kyron.bio raises €5.5M to tackle a major challenge in biologic drug development using sugar molecules

bottom of page